位置:首页 > 产品库 > Bexarotene-d4
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Bexarotene-d4
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Bexarotene-d4图片
规格:98%
分子量:352.5
包装与价格:
包装价格(元)
500ug询价
1mg询价

A neuropeptide with diverse biological activities
货号:ajcx21798
CAS:N/A
分子式:C24H24D4O2
分子量:352.5
溶解度:DMF: 20 mg/ml,DMF:PBS (pH 7.2)(1:3): 0.25 mg/ml,DMSO: 10 mg/ml,Ethanol: 0.5 mg/ml
纯度:98%
存储:Store at -20°C
库存:现货

Background:

Bexarotene-d4is intended for use as an internal standard for the quantification of bexarotene by GC- or LC-MS. Bexarotene is a high-affinity ligand for retinoid X receptors (RXRs) (EC50s = 28, 25, and 20 nM for RXRα, β, and γ, respectively).1It inhibits cell cycle progression, induces apoptosis, prevents or overcomes multidrug resistance through multidrug resistance protein 1 (MDR1), and blocks angiogenesis and metastasis, making it a promising chemopreventive agent against cancer.2,3Bexarotene also, through RXR activation, stimulates clearance of soluble β-amyloid, reduces plaque area, and reverses deficits related to Alzheimer's disease in mice.4


1.Boehm, M.F., Zhang, L., Zhi, L., et al.Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cellsJ. Med. Chem.38(16)3146-3155(1995) 2.Bischoff, E.D., Gottardis, M.M., Moon, T.E., et al.Beyond tamoxifen: The retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinomaCancer Res.58(3)479-484(1998) 3.Qu, L., and Tang, X.Bexarotene: A promising anticancer agentCancer Chemother. Pharmacol.65(2)201-205(2010) 4.Cramer, P.E., Cirrito, J.R., Wesson, D.W., et al.ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse modelsScience335(6057)1503-1506(2012)

 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024